Patents by Inventor Greta Cary

Greta Cary has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110027371
    Abstract: The present invention is directed to nanoparticulate compositions comprising statin such as lovastatin or simvastatin. The statin particles of the composition have an effective average particle size of less than about 2000 nm. In another aspect of this invention, novel combinations of statins and other cholesterol lowering agents are described and methods of using same are taught.
    Type: Application
    Filed: March 6, 2006
    Publication date: February 3, 2011
    Inventors: Eugene R. Cooper, Douglas Hovey, Greta Cary, Marie Lindner, Elaine Liversidge, Gary G. Liversidge, Tuula Ryde
  • Publication number: 20080213378
    Abstract: The present invention is directed to nanoparticulate compositions comprising statin such as lovastatin or simvastatin. The statin particles of the composition have an effective average particle size of less than about 2000 nm. In another aspect of this invention, novel combinations of statins and other cholesterol lowering agents are described and methods of using same are taught.
    Type: Application
    Filed: October 31, 2007
    Publication date: September 4, 2008
    Inventors: Eugene R. Cooper, Douglas Hovey, Greta Cary, Marie Lindner, Elaine Liversidge, Gary G. Liversidge, Tuula Ryde
  • Publication number: 20080107741
    Abstract: Nanoparticulate compositions comprising at least one poorly soluble angiogenesis inhibitor and at least one surface stabilizer are described. The nanoparticulate compositions have an average particle size of less than about 2000 nm. The invention also describes methods of making and using such compositions.
    Type: Application
    Filed: October 30, 2007
    Publication date: May 8, 2008
    Inventors: Elaine Merisko-Liversidge, H. Bosch, Greta Cary, John Pruitt, Tuula Ryde, Rajeev Jain, Amy Walters
  • Publication number: 20080050461
    Abstract: Nanoparticulate compositions comprising at least one poorly soluble angiogenesis inhibitor and at least one surface stabilizer are described. The nanoparticulate compositions have an average particle size of less than about 2000 nm. The invention also describes methods of making and using such compositions.
    Type: Application
    Filed: October 30, 2007
    Publication date: February 28, 2008
    Inventors: Elaine Merisko-Liversidge, H. William Bosch, Greta Cary, John Pruitt, Tuula Ryde, Rajeev Jain, Amy Walters
  • Publication number: 20060193920
    Abstract: Nanoparticulate compositions comprising at least one poorly soluble MAP kinase inhibitor and at least one surface stabilizer are described. The nanoparticulate compositions have an average particle size of less than about 2000 nm. The invention also describes methods of making and using such compositions.
    Type: Application
    Filed: December 7, 2005
    Publication date: August 31, 2006
    Inventors: H. Bosch, Greta Cary, Douglas Hovey, Rajeev Jain, Laura Kline, Elaine Merisko-Liversidge, Kevin Ostrander
  • Publication number: 20040033267
    Abstract: Nanoparticulate compositions comprising at least one poorly soluble angiogenesis inhibitor and at least one surface stabilizer are described. The nanoparticulate compositions have an average particle size of less than about 2000 nm. The invention also describes methods of making and using such compositions.
    Type: Application
    Filed: March 20, 2003
    Publication date: February 19, 2004
    Applicant: Elan Pharma International Ltd.
    Inventors: Elaine Merisko-Liversidge, H. William Bosch, Greta A. Cary, John Pruitt, Tuula Ryde, Rajeev Jain, Amy Walters